Lindenwold Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $598K | Sell |
1,905
-2
| -0.1% | -$628 | 0.31% | 60 |
|
|
2025
Q1 | $581K | Sell |
1,907
-47
| -2% | -$14.3K | 0.32% | 60 |
|
|
2024
Q4 | $649K | Sell |
1,954
-72
| -4% | -$23.9K | 0.35% | 58 |
|
|
2024
Q3 | $676K | Buy |
2,026
+32
| +2% | +$10.7K | 0.34% | 57 |
|
|
2024
Q2 | $821K | Sell |
1,994
-52
| -3% | -$21.4K | 0.44% | 55 |
|
|
2024
Q1 | $827K | Sell |
2,046
-7
| -0.3% | -$2.83K | 0.44% | 53 |
|
|
2023
Q4 | $629K | Sell |
2,053
-17
| -0.8% | -$5.21K | 0.36% | 58 |
|
|
2023
Q3 | $501K | Buy |
2,070
+12
| +0.6% | +$2.91K | 0.31% | 58 |
|
|
2023
Q2 | $494K | Sell |
2,058
-484
| -19% | -$116K | 0.3% | 64 |
|
|
2023
Q1 | $478K | Buy |
2,542
+14
| +0.6% | +$2.63K | 0.3% | 69 |
|
|
2022
Q4 | $537K | Sell |
2,528
-279
| -10% | -$59.3K | 0.36% | 71 |
|
|
2022
Q3 | $441K | Buy |
2,807
+32
| +1% | +$5.03K | 0.33% | 72 |
|
|
2022
Q2 | $415K | Buy |
2,775
+63
| +2% | +$9.42K | 0.3% | 75 |
|
|
2022
Q1 | $444K | Buy |
2,712
+148
| +6% | +$24.2K | 0.27% | 78 |
|
|
2021
Q4 | $558K | Buy |
+2,564
| New | +$558K | 0.33% | 72 |
|